Creative Medical Technology Holdings, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Creative Medical Technology Holdings, Inc. (CELZ) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$157.67 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2025-11-07
- Creative Medical Technology Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$52.56K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was -$52.56K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-03-31 was -$52.56K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2024-09-30 was -$61.48K, a 166.67% decline year-over-year.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed |
|---|---|---|---|---|---|---|
| 2025-09-30 | -$52.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$105.11K derived: sum of 2 quarters · filed 2025-11-07 | -$157.67K 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | -$52.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$105.11K 10-Q · filed 2025-08-08 | ||||
| 2025-03-31 | -$52.56K 10-Q · filed 2025-05-09 | |||||
| 2024-09-30 | -$61.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$122.96K derived: sum of 2 quarters · filed 2025-11-07 | -$209.64K 10-Q · filed 2025-11-07 | $209.64K 10-Q · filed 2024-11-08 | ||
| 2024-06-30 | -$61.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$148.16K 10-Q · filed 2025-08-08 | $148.16K 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | -$86.68K 10-Q · filed 2025-05-09 | $86.68K 10-Q · filed 2024-05-10 | ||||
| 2023-09-30 | $92.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $184.43K derived: sum of 2 quarters · filed 2024-11-08 | $276.64K 10-Q · filed 2024-11-08 | -$276.64K 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $92.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $184.43K 10-Q · filed 2024-08-09 | -$184.43K 10-Q · filed 2023-08-11 | |||
| 2023-03-31 | $92.21K 10-Q · filed 2024-05-10 | -$92.21K 10-Q · filed 2023-05-12 | ||||
| 2022-09-30 | -$64.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$64.96K derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $64.96K 10-Q · filed 2023-08-11 | ||||
| 2022-03-31 | $64.96K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |